Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice

Neurobiology of Aging

Volumn 33, Issue 8, 2012, Pages 1609-1623

  Wykes, Robert ^a   Kalmbach, Abigail ^a   Eliava, Marina ^a   Waters, Jack ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Abeta; Alzheimer's disease; Beta amyloid; Dendrite; Hippocampus; Intracellular calcium; Potassium channel; Pyramidal neuron

Indexed keywords

4 AMINOPYRIDINE; CALCIUM ION; DELAYED RECTIFIER POTASSIUM CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV3.1B; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENDRITE; ELECTROPHYSIOLOGY; FEMALE; HIPPOCAMPAL CA1 REGION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; STRATUM RADIATUM;

ACTION POTENTIALS; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE PROGRESSION; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; PYRAMIDAL CELLS;

EID: 84861844669     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.05.001     Document Type: Article

References (72)

1. Ambrée O., Touma C., Görtz N., Keyvani K., Paulus W., Palme R., Sachser N. Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice. Neurobiol. Aging 2006, 27:955-964.
2. Angulo E., Noé V., Casadó V., Mallol J., Gomez-Isla T., Lluis C., Ferrer I., Ciudad C.J., Franco R. Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. J. Neurochem 2004, 10:547-557.
3. Bean B.P. The action potential in mammalian central neurons. Nat. Rev. Neurosci 2007, 8:451-465.
4. Bezprozvanny I., Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 2008, 31:454-463.
5. Brown J.T., Richardson J.C., Collingridge G.L., Randall A.D., Davies C.H. Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice. Hippocampus 2005, 15:110-117.
6. Camandola S., Mattson M.P. Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim. Biophys. Acta 2011, 1813:965-973.
7. Chauhan N.B., Siegel G.J., Lichtor T. Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice. J. Neurosci. Res 2004, 78:732-741.
8. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci 1999, 3:271-276.
9. + current in hippocampal CA1 pyramidal neurons. Biochem. Biophys. Res. Commun 2005, 338:1913-1919.
10. Chishti M.A., Yang D.-S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., St George-Hyslop P., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem 2001, 276:21562-21570.
11. Clements J.D., Bekkers J.M. Detection of spontaneous synaptic events with an optimally scaled template. Biophys. J 1997, 73:220-229.
12. Coles B., Wilton L.A., Good M., Chapman P.F., Wann K.T. Potassium channels in hippocampal neurones are absent in a transgenic but not in a chemical model of Alzheimer's disease. Brain Res 2008, 1190:1-14.
13. Dewachter I., Filipkowski R.K., Priller C., Ris L., Neyton J., Croes S., Terwel D., Gysemans M., Devijver H., Borghgraef P., Godaux E., Kaczmarek L., Herms J., Van Leuven F. Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol. Aging 2007, 2:241-256.
14. Ekinci F.J., Malik K.U., Shea T.B. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration. J. Biol. Chem 1999, 274:30322-30327.
15. Golding N.L., Jung H.Y., Mickus T., Spruston N. Dendritic calcium spike initiation and repolarization are controlled by distinct potassium channel subtypes in CA1 pyramidal neurons. J. Neurosci 1999, 19:8789-8798.
16. Goldstein S.S., Rall W. Changes of action potential shape and velocity for changing core conductor geometry. Biophys. J 1974, 14:731-757.
17. + current in rat hippocampal neurons. Biophys. J 1996, 70:296-304.
18. Green K.N., LaFerla F.M. Linking calcium to Aβ and Alzheimer's Disease. Neuron 2008, 59:190-194.
19. + channels, types Kv1.1, 1 .2, 1 .3, 1 .5, and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol 1994, 45:1227-1234.
20. Guntern R., Bouras C., Hof P.R., Vallet P.G. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 1992, 48:8-10.
21. Hardy J. A hundred years of Alzheimer's disease research. Neuron 2006, 52:3-13.
22. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
23. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:3228-3233.
24. Hyde L.A., Kazdoba T.M., Grilli M., Lozza G., Brusa R., Zhang Q., Wong G.T., McCool M.F., Zhang L., Parker E.M., Higgins G.A. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav. Brain Res 2005, 160:344-355.
25. Jacobsen J.S., Wu C.C., Redwine J.M., Comery T.A., Arias R., Bowlby M., Martone R., Morrison J.H., Pangalos M.N., Reinhart P.H., Bloom F.E. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5161-5166.
26. Jolas T., Zhang X.S., Zhang Q., Wong G., Del Vecchio R., Gold L., Priestley T. Long-term potentiation is increased in the CA1 area of the hippocampus of APP(swe/ind) CRND8 mice. Neurobiol. Dis 2002, 11:394-409.
27. Kerrigan T.L., Atkinson L., Peers C., Pearson H.A. Modulation of 'A'-type K+ current by rodent and human forms of amyloid β protein. Neuroreport 2008, 19:839-843.
28. Kim J., Wei D.-S., Hoffman D.A. Kv4 potassium channel subunits control action potential repolarization and frequency-dependent broadening in rat hippocampal CA1 pyramidal neurons. J. Physiol 2005, 569:41-57.
29. Kim J.H., Anwyl R., Suh Y.H., Djamgoz M.B., Rowan M.J. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci 2001, 21:1327-1333.
30. Kim K.S., Miller D.L., Sapienza V.J., Chen C.-M.J., Bai C., Grundke-Iqbal I., Currie J.R., Wisniewski H.M. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Comm 1988, 2:121-130.
31. Kim K.S., Wen G.Y., Bancher C., Chen C.M.J., Sapienza V.J., Hong H., Wisniewski H.M. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci Res Comm 1990, 7:113-122.
32. Knobloch M., Farinelli M., Konietzko U., Nitsch R.M., Mansuy I.M. Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J. Neurosci 2007, 27:7648-7653.
33. Kuchibhotla K.V., Goldman S.T., Lattarulo C.R., Wu H.Y., Hyman B.T., Bacskai B.J. Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 2008, 59:214-225.
34. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res 1999, 840:23-35.
35. LeVine H. Quantification of β-sheet amyloid fibril structures with thioflavin T. Meth. Enzymol 1999, 309:274-284.
36. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
37. Ma M., Koester J. Consequences and mechanisms of spike broadening of R20 cells in Aplysia californica. J. Neurosci 1995, 15:6720-6734.
38. Ma M., Koester J. The role of K+ currents in frequency-dependent spike broadening in Aplysia R20 neurons: a dynamic-clamp analysis. J. Neurosci 1996, 16:4089-4101.
39. + channels of fast-spiking interneurons and pyramidal neurons of rat hippocampus. J. Neurosci 1998, 18:8111-8125.
40. 4-AP currents and Kv3.1 potassium channel transcripts in cortical neurons that develop distinct firing phenotypes. J. Neurosci 1997, 17:3136-3147.
41. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. PNAS 1985, 82:4245-4249.
42. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci 1992, 12:376-389.
43. Nomura I., Kato N., Kita T., Takechi H. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci. Lett 2005, 391:1-6.
44. Oertner T.G., Sabatini B.L., Nimchinsky E.A., Svoboda K. Facilitation at single synapses probed with optical quantal analysis. Nat. Neurosci 2002, 5:657-664.
45. Palop J.J., Mucke L. Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci 2010, 13:812-818.
46. Pannaccione A., Boscia F., Scorziello A., Adornetto A., Castaldo P., Sirabella R., Taglialatela M., Di Renzo G.F., Annunziato L. Up-regulation and increased activity of Kv34 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death. Mol. Pharm 2007, 72:665-673.
47. + current. Neurobiol. Aging 2006, 27:1673-1683.
48. + channels by amyloid β-protein fragment 31-35 in membrane patches excised from hippocampal neurons. Acta Physiol. Sin 2001, 53:198-204.
49. Ranck J.B. Studies on single neurons in dorsal hippocampal formation and septum in unrestrained rats. I. Behavioral correlates and firing repertoires. Exp. Neurol 1973, 41:461-531.
50. Raymond C.R., Ireland D.R., Abraham W.C. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus. Brain Res 2003, 968:263-272.
51. Rettig J., Wunder F., Stocker M., Lichtinghagen R., Mastiaux F., Beckh S., Kues W., Pedarzani P., Schröter K.H., Ruppersberg J.P., Veh R., Pongs O. Characterization of a Shaw-related potassium channel family in rat brain. EMBO J 1992, 11:2473-2486.
52. Sabatini B.L., Oertner T.G., Svoboda K. The life cycle of Ca(2+) ions in dendritic spines. Neuron 2002, 33:439-452.
53. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer. Nat. Med 2008, 14:837-842.
54. + channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. J. Physiol 1999, 521:135-146.
55. Sjöström P.J., Nelson S.B. Spike timing, calcium signals and synaptic plasticity. Curr. Opin. Neurobiol 2002, 12:305-314.
56. Small D.H., Mok S.S., Bornstein J.C. Alzheimer's disease and Abeta toxicity: From top to bottom. Nat. Rev. Neurosci 2001, 2:595-598.
57. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-β. Nat. Neurosci 2005, 8:1051-1058.
58. Spruston N., Schiller Y., Stuart G., Sakmann B. Activity-dependent action potential invasion and calcium influx into hippocampal CA1 dendrites. Science 1995, 268:297-300.
59. Stutzmann G.E. Calcium dysregulation, IP3 signaling, and Alzheimer's Disease. Neuroscientist 2005, 11:110-115.
60. Supnet C., Grant J., Kong H., Westaway D., Mayne M. Amyloid-beta-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice. J. Biol. Chem 2006, 281:38440-38447.
61. Townsend M., Shankar G.M., Mehta T., Walsh D.M., Selkoe D.J. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol 2006, 572:477-492.
62. 2+ channels: a possible involvement of free radicals. J. Neurochem 1997, 68:265-271.
63. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
64. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., Trommer B.L. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 2002, 924:133-140.
65. Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci 2004, 24:3370-3378.
66. Waters J., Helmchen F. Background synaptic activity is sparse in neocortex. J. Neurosci 2006, 26:8267-8277.
67. Waters J., Nevian T., Sakmann B., Helmchen F. Action potentials in dendrites and spike-timing-dependent plasticity. Molecular Mechanisms of Memory. Vol. 4 of Learning and Memory. A Comprehensive Reference 2008, 803-828. Elsevier, Oxford. J.D. Sweatt (Ed.).
68. Zhu Y.J., Lin H., Lal R. Fresh and nonfibrillar amyloid ß protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AßP-channel-mediated cellular toxicity. FASEB J 2000, 14:1244-1254.
69. Waters J., Schaefer A., Sakmann B. Backpropagating action potentials in neurones: measurement, mechanisms and potential functions. Prog. Biophys. Mol. Biol 2005, 87:145-170.
70. Weiser M., Vega-Saenz de Miera E., Kentros C., Moreno H., Franzen L., Hillman D., Baker H., Rudy B. Differential expression of Shaw-related K+ channels in the rat central nervous system. J. Neurosci 1994, 14:949-972.
71. Wu R.L., Barish M.E. Two pharmacologically and kinetically distinct transient potassium currents in cultured embryonic mouse hippocampal neurons. J. Neurosci 1992, 12:2235-2246.
72. Ye H., Jalini S., Mylvaganam S., Carlen P. Activation of large-conductance Ca(2+)-activated K(+) channels depresses basal synaptic transmission in the hippocampal CA1 area in APP (swe/ind) TgCRND8 mice. Neurobiol. Aging 2010, 31:591-604.